Press Release (Revised) Jul 10 2024
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a revised press release announcing that it received final approval from the USFDA for Sacubitril and Valsartan Tablets. These tablets are used to treat chronic heart failure in adults and will be manufactured in Ahmedabad, India. The press release highlights that the drug had significant annual sales in the United States.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jul 10 2024
- Press Release Jul 04 2024
- Press Release Jun 28 2024
- Press Release Jun 14 2024
- Press Release May 24 2024
Later from Zydus Lifesciences
- Press Release Jul 17 2024
- Press Release Jul 19 2024
- Zydus Lifesciences Limited Press Release Jul 22 2024
- Press Release Jul 23 2024
- Press Release Jul 31 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences